Long Non-coding RNA TINCR As Potential Biomarker and Therapeutic Target for Cancer

Overview

Journal Life Sci

Publisher Elsevier

Specialties Biochemistry
Biology
Physiology

Date 2020 Jul 6

PMID 32622950

Citations 39

Authors

Uttam Sharma

Tushar Singh Barwal

Akshay Malhotra

Neha Pant

Vivek

Damayanti Dey

Ashima Gautam

Hardeep Singh Tuli

Karen M Vasquez

Aklank Jain

Affiliations

Soon will be listed here.

Abstract

Despite the recent scientific advances made in cancer diagnostics and therapeutics, cancer still remains the second leading cause of death worldwide. Thus, there is a need to identify new potential biomarkers/molecular targets to improve the diagnosis and treatment of cancer patients. In this regard, long non-coding RNAs (lncRNAs), a type of non-coding RNA molecule, have been found to play important roles in diverse biological processes, including tumorigenesis, and may provide new biomarkers and/or molecular targets for the improved detection of treatment of cancer. For example, one lncRNA, tissue differentiation-inducing non-protein coding RNA (TINCR) has been found to be significantly dysregulated in many cancers, and has an impact on tumor development and progression through targeting pivotal molecules in cancer-associated signaling pathways. Hence, based on recent discoveries, herein, we discuss the regulatory functions and the underlying mechanisms of how TINCR regulates signaling pathways attributed to cancer hallmarks associated with the pathogenesis of various human cancers. We also highlight studies assessing its potential clinical utility as a biomarker/target for early detection, cancer risk stratification, and personalized cancer therapies.

Citing Articles

Overexpression of lncRNA TINCR inhibits cutaneous squamous cell carcinoma cells through promotes methylation of Myc and TERC genes.

Wang L, Wang Y, Xu L Arch Dermatol Res. 2025; 317(1):559.

PMID: 40072633 PMC: 11903621. DOI: 10.1007/s00403-025-03964-y.

LncRNAs in modulating cancer cell resistance to paclitaxel (PTX) therapy.

Alkhathami A, Pallathadka H, Shah S, Ganesan S, Sharma A, Devi S Med Oncol. 2024; 42(1):28.

PMID: 39671022 DOI: 10.1007/s12032-024-02577-1.

Exosome-mediated Transfer of lncRNA in Liver Associated Diseases; Uncovered Truths.

Saleh R, Hamad H, Najim M, Menon S, Kaur M, Sivaprasad G Cell Biochem Biophys. 2024; .

PMID: 39567423 DOI: 10.1007/s12013-024-01617-x.

LINC00941 is a diagnostic biomarker for lung adenocarcinoma and promotes tumorigenesis through cell autophagy.

Yang Q, Yong X, Chen X, Huang R, Wang X, Xu Z J Cell Mol Med. 2024; 28(19):e70076.

PMID: 39392103 PMC: 11467743. DOI: 10.1111/jcmm.70076.

Uttam V, Kapoor H, Rana M, Yadav R, Prakash H, Jain M Cancer Inform. 2024; 23:11769351241276757.

PMID: 39282627 PMC: 11401149. DOI: 10.1177/11769351241276757.

References

Chen H, Hsu L, Shia Y, Lin M, Lin C . The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway. Biochem Pharmacol. 2012; 84(9):1143-53. DOI: 10.1016/j.bcp.2012.08.011. View

Tuo Z, Zhang J, Xue W . LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway. Biochem Biophys Res Commun. 2018; 499(4):875-881. DOI: 10.1016/j.bbrc.2018.04.010. View

Tu K, Zheng X, Zan X, Han S, Yao Y, Liu Q . Evaluation of Fbxw7 expression and its correlation with the expression of c-Myc, cyclin E and p53 in human hepatocellular carcinoma. Hepatol Res. 2012; 42(9):904-10. DOI: 10.1111/j.1872-034X.2012.01005.x. View

Fang Y, Xue J, Shen Q, Chen J, Tian L . MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma. Hepatology. 2012; 55(6):1852-62. DOI: 10.1002/hep.25576. View

Liu X, Ma J, Xu F, Li L . TINCR suppresses proliferation and invasion through regulating miR-544a/FBXW7 axis in lung cancer. Biomed Pharmacother. 2018; 99:9-17. DOI: 10.1016/j.biopha.2018.01.049. View

Zhang H, Yang F, Yan Y, Che J, Zheng J . High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma. Int J Clin Exp Pathol. 2014; 7(9):5801-9. PMC: 4203192. View

Xu S, Kong D, Chen Q, Ping Y, Pang D . Oncogenic long noncoding RNA landscape in breast cancer. Mol Cancer. 2017; 16(1):129. PMC: 5525255. DOI: 10.1186/s12943-017-0696-6. View

Chen F, Qi S, Zhang X, Wu J, Yang X, Wang R . lncRNA PLAC2 activated by H3K27 acetylation promotes cell proliferation and invasion via the activation of Wnt/β‑catenin pathway in oral squamous cell carcinoma. Int J Oncol. 2019; 54(4):1183-1194. PMC: 6411352. DOI: 10.3892/ijo.2019.4707. View

Rui X, Wang L, Pan H, Gu T, Shao S, Leng J . LncRNA GAS6-AS2 promotes bladder cancer proliferation and metastasis via GAS6-AS2/miR-298/CDK9 axis. J Cell Mol Med. 2018; 23(2):865-876. PMC: 6349183. DOI: 10.1111/jcmm.13986. View

10.

Xu T, Wang Y, Xiong W, Ma P, Wang W, Chen W . E2F1 induces TINCR transcriptional activity and accelerates gastric cancer progression via activation of TINCR/STAU1/CDKN2B signaling axis. Cell Death Dis. 2017; 8(6):e2837. PMC: 5520882. DOI: 10.1038/cddis.2017.205. View

11.

Trinh X, Tjalma W, Vermeulen P, Van den Eynden G, Van der Auwera I, Van Laere S . The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer. Br J Cancer. 2009; 100(6):971-8. PMC: 2661789. DOI: 10.1038/sj.bjc.6604921. View

12.

Sheng N, Yan L, Wu K, You W, Gong J, Hu L . TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer. Cell Death Dis. 2018; 9(3):402. PMC: 5852242. DOI: 10.1038/s41419-018-0434-z. View

13.

Khandelwal A, Malhotra A, Jain M, Vasquez K, Jain A . The emerging role of long non-coding RNA in gallbladder cancer pathogenesis. Biochimie. 2016; 132:152-160. PMC: 6282167. DOI: 10.1016/j.biochi.2016.11.007. View

14.

Kretz M, Siprashvili Z, Chu C, Webster D, Zehnder A, Qu K . Control of somatic tissue differentiation by the long non-coding RNA TINCR. Nature. 2012; 493(7431):231-5. PMC: 3674581. DOI: 10.1038/nature11661. View

15.

Lavoie H, Therrien M . Regulation of RAF protein kinases in ERK signalling. Nat Rev Mol Cell Biol. 2015; 16(5):281-98. DOI: 10.1038/nrm3979. View

16.

Gautreau A, Louvard D, Arpin M . Morphogenic effects of ezrin require a phosphorylation-induced transition from oligomers to monomers at the plasma membrane. J Cell Biol. 2000; 150(1):193-203. PMC: 2185562. DOI: 10.1083/jcb.150.1.193. View

17.

Scott G, Goga A, Bhaumik D, Berger C, Sullivan C, Benz C . Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J Biol Chem. 2006; 282(2):1479-86. DOI: 10.1074/jbc.M609383200. View

18.

Luo M, Li Z, Wang W, Zeng Y, Liu Z, Qiu J . Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression. FEBS J. 2013; 280(7):1709-16. DOI: 10.1111/febs.12185. View

19.

Zhuang C, Li J, Liu Y, Chen M, Yuan J, Fu X . Tetracycline-inducible shRNA targeting long non-coding RNA PVT1 inhibits cell growth and induces apoptosis in bladder cancer cells. Oncotarget. 2015; 6(38):41194-203. PMC: 4747399. DOI: 10.18632/oncotarget.5880. View

20.

Ma X, Huang C, Luo D, Wang Y, Tang R, Huan X . Tag SNPs of long non-coding RNA TINCR affect the genetic susceptibility to gastric cancer in a Chinese population. Oncotarget. 2016; 7(52):87114-87123. PMC: 5349975. DOI: 10.18632/oncotarget.13513. View